Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma

Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma

Abstract Oral squamous cell carcinoma (OSCC) remains one of the most challenging clinical problems in the field due to its high rate of locoregional and distant metastases. However, studies that assess the association between aspirin use and survival in patients with OSCC are limited. Moreover, pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sheng-Dean Luo, Shao-Chun Wu, Wei-Chih Chen, Ching-Nung Wu, Tai-Jan Chiu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Chang-Chun Hsiao, Chang-Han Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/5402fd33797f41dea3bf84e48b122b74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares